1,066 results on '"Garey, Kevin W."'
Search Results
2. Comparison of Risk Stratification Approaches to Identify Patients with Clostridioides difficile Infection at Risk for Multidrug-Resistant Organism Gut Microbiota Colonization
3. Development and validation of LC-MS/MS for quantifying omadacycline from stool for gut microbiome studies
4. Microscopy methods for Clostridioides difficile
5. Donor-recipient specificity and age-dependency in fecal microbiota therapy and probiotic resolution of gastrointestinal symptoms
6. Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile
7. Increased Prevalence of Clostridioides difficile Infection Among Pediatric Oncology Patients: Risk Factors for Infection and Complications
8. Emerging Options for the Prevention and Management of Clostridioides difficile Infection
9. Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer
10. Erratum to “Development and validation of LC-MS/MS for quantifying omadacycline from stool for gut microbiome studies” [J. Chromatogr. B 1236 (2024) 124057]
11. Fusobacterium nucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus
12. Redefining Clostridioides difficile infection antibiotic response and clinical outcomes
13. Development of the invasive candidiasis discharge [I Can discharge] model: a mixed methods analysis
14. Nonmammalian models to study Clostridioides difficile infection; a systematic review
15. Heterogeneity and lyophilization comparison of stool processing for gastrointestinal bile acid measurement by LC-MS/MS
16. Estimating Clostridioides difficile infection-associated readmission rates: A systematic review and meta-analysis
17. Appropriate cleaning reduces potential risk of spore transmission from patients with Clostridioides difficile infection treated in outpatient infusion centers
18. Multi-country surveillance of Clostridioides difficile demonstrates high prevalence of spores in non-healthcare environmental settings
19. Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life
20. Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response.
21. Absence of Toxemia in Clostridioides difficile Infection: Results from Ultrasensitive Toxin Assay of Serum
22. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains
23. Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile
24. A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response
25. Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of United States Hospitals
26. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation
27. Visualization of fidaxomicin association with the exosporium layer of Clostridioides difficile spores
28. Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus
29. Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut–Brain Axis
30. RISEC: Rotational Invariant Segmentation of Elongated Cells in SEM Images with Inhomogeneous Illumination
31. Using the Theory of Planned Behavior to Evaluate Factors That Influence PharmD Students’ Intention to Attend Lectures
32. Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh
33. Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers
34. Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence
35. 277. A Functional OMICs Evaluation of Omadacycline to Understand Anti-Clostridioides difficile Protective Effects
36. 2164. Resistome patterns associated with vancomycin non-susceptibility in clinical Clostridioides difficile isolates
37. 685. Early Experience with a Simple Administration of a Novel Fecal Microbiome Replacement for Prevention of Recurrent Clostridioides difficile
38. 2063. Elucidating the Gram-Positive Selective Spectrum Activity of Ibezapolstat; Secondary Analysis from the phase 2a trial
39. 366. Association Between Gut Microbiota and Health-Related Quality of Life in Patients with Recurrent Clostridioides difficile Infection: Results from the PUNCH CD3 Clinical Trial
40. 674. Host and Pathogen Risk Factors for Fulminant Clostridioides difficile Infection
41. S1083 Association of Microbiome Composition and Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Phase 3, Randomized, Placebo-Controlled Clinical Trial
42. Reply to Fabre et al
43. The metabolic profile of Bifidobacterium dentium reflects its status as a human gut commensal
44. Molecular epidemiology of Clostridioides difficile in domestic dogs and zoo animals
45. Economic health care costs of blood culture contamination: A systematic review
46. Increased Prevalence of Clostridioides difficile Infection Among Pediatric Oncology Patients: Risk Factors for Infection and Complications.
47. Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers.
48. Detectable Vancomycin Stool Concentrations in Hospitalized Patients with Diarrhea Given Intravenous Vancomycin
49. Effect of Fecal Microbiota, live-jslm (RBL) on Health-Related Quality of Life in Patients with Recurrent Clostridioides difficile Infection: Results from the PUNCH CD3 Clinical Trial
50. Outcomes associated with Clostridium difficile infection in patients with chronic liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.